Aurinia: 3Q Earnings Snapshot

November 14, 2019 GMT

VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $19 million in its third quarter.

The Victoria, British Columbia-based company said it had a loss of 21 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.

The biotechnology company posted revenue of $230,000 in the period, which topped Street forecasts. Four analysts surveyed by Zacks expected $50,000.

Aurinia shares have decreased 25% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.09, a decrease of slightly more than 1% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH